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Abstract:  
Background: Diabetes mellitus and gall bladder stones are both common and costly diseases. Increasing age, female 
gender, overweight, familial history of the disease and type 2 diabetes mellitus is all associated with an increased risk of 
gallstones. Several studies from around the world reported an increased prevalence of gall bladder stones in patients with 
diabetes mellitus. Aims and objectives: The aim of this study was to define the frequency of gall bladder stones among 
Libyan diabetics and to evaluate the possible associated risk factors in these patients. Patients and methods: A case-
control study was performed during 2007 at Benghazi Diabetes and endocrinology Center. The study involved 161 randomly 
selected type-2 diabetic patients under regular follow up at the center, and 166 age and sex matched non-diabetic 
outpatients at the 7th of October teaching hospital. Real-time abdominal ultrasound was performed by two radiologists to 
examine the abdomen after an overnight fast. Results: About 40% of the diabetic cohort had gall bladder stones as compared 
to 17.5% of non-diabetic patients. Females were significantly more affected than males. Patients with gall bladder stones 
were significantly older and had a significantly higher body mass index than those without stones. Conclusion: The 
prevalence of gallstones in Libyan diabetic patients is higher than the rates reported in other parts of the world. Libyan 
diabetic patients with gallstones tend to be older and more obese than those without gallstones. Duration of diabetes mellitus 
and type of treatment does not seem to influence the frequency of gall bladder stones among Libyan diabetics. 
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Introduction 
Diabetes mellitus (DM) and gall bladder stones (GBS) 
are both common and costly diseases. In general, GBS are 
more frequent in females due to hormonal factors. 
Increasing age, overweight, family history of GBS and type 
2 DM are all associated with an increased risk of gallstones 
[1]. In 1993 Abdulwahab and Karim reported that about 
77% of all operations performed at Al-Hawari Teaching 
Hospital in Benghazi, Libya, were cholecystectomies, with 
a female to male ratio of 4:1 [2]. In a recent report from 
Benghazi the prevalence of DM among cholecystectomized 
patients was 9.9% [3]. Several studies from across the 
world reported an increased prevalence of GBS in patients 
with DM [4-8]. How diabetes predisposes to gallstones is 
not well understood. However, hypertriglyceridemia, 
autonomic neuropathy (leading to gallbladder hypomotility 
and biliary stasis) [4] and hyperinsulinemia [1,5] have 
been suggested as contributing factors to the increased 
risk of GBS development in diabetics. An Italian study 
showed that the prevalence of gallstone disease is 
significantly higher in diabetic patients than in the general 
population (24.8% vs.13.8%) [6]. Another study from 
New Zeeland reported a GBS prevalence of 32.7% among 
diabetic patients as compared to 20.8% in controls [7]. To 
the best of our knowledge, no data has been reported 
from Libya on the prevalence of GBS, neither in the 
general population nor in diabetic patients. 
 
Aims and objectives  
The aim of this study was to determine the frequency of 
GBS among Libyan diabetics in comparison to non diabetic 
outpatients and to evaluate the possible associated factors 
in this high risk group. 
 
Patients and methods 
A case-control study was performed during 2007. The 
study involved 161(107 females and 54 males) randomly 
selected type-2 diabetic patients under regular follow up 
at Benghazi diabetes and endocrinology center (BDEC). 
The control group consisted of 166 age and sex matched 
non diabetic patients (109 females and 57 males) 
recruited from subjects attending the medical outpatient 
department of 7th of October teaching hospital for check 
up.  
 
Patients were interviewed to obtain the following 
information: age, sex, duration of DM, type of treatment, 
parity, history of cholecystectomy, history of GBS (patients 
with previous history of GBS were included), type of GBS 
(single or multiple), use of oral contraceptives, and history 
of GBS in first degree relatives. Weight and height were 
measured and body mass index (BMI) was calculated for 
each patient. Obesity was defined according to WHO as 
BMI  ≥ 30 kg/m². Two radiologists employed real-time 
ultrasound to examine the abdomen after an overnight 
fast. Data were analyzed with the Statistical Package for 
the Social Sciences (Windows version 11.0; SPSS Inc, 
Chicago, IL). Data were expressed as mean ± standard 
deviation (SD). Differences between groups were 
evaluated by using the Chi squared test and independent 
samples t-test. P-values <0.05 were considered 
statistically significant. 
 
Results  
The mean age of the diabetic cohort was 52.5±11.7 
years (50.8±10.3 years for females and 56±13.5 years for 
males). The mean age of the control group was 49.5±19.9 
years (47.7±19 years for females and 52.7±21 years for 
males). 
 
GBS was observed in 39.75% of the diabetic cohort and 
in 17.5% of the control (2.27 times higher) (Table 1), the 
prevalence was significantly higher in female diabetics 
than in male diabetics (47% vs.26%, p=0.01). 
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Table 1 Comparison between diabetics and control group 
 DM  NO  DM  P-value 
Number   161  166   
Females   107  109   
Males 54  57   
GBS (%)  39.8%  17.5%  0.000 
GBS % in F  46.7%  18.3%  0.000 
GBS % in M  25.9%  15.8%  0.18 
Mean age (±SD)  52.5±11.7 
years 
49.5±19.9 
years 
0.095 
Mean age of F 
(±SD) 
50.8±10.3 
years 
47.7±19 
years 
0.14 
Mean age of M 
(±SD) 
56±13.5 
years 
52.7±21 
years 
0.34 
Multiple GBS  75%  of  all 
GBS 
72.4% of all 
GBS 
0.79 
Female=F, Male=M, DM= diabetes mellitus, GBS= gallbladder 
stone, SD= standard deviation  
 
Table 2 Comparison between diabetics 
with GBS and without GBS 
 Diabetics  with 
GBS 
Diabetics 
without GBS 
P-
value 
Females 78%  59%  0.011 
Age  55.5± 9.7 years  50.5±  12.5 
years 
0.007 
DM 
duration(±SD) 
12.5±7.7 years  10.6± 6.8years  0.11 
Mean 
Weight(±SD) 
84.7±14.9 kg 
(58-124) 
82.2±16.9 kg 
(51-123) 
0.33 
Mean BMI 
(±SD) 
34.78±6.29 
kg/m²(21.5-
55.1) 
32.2±7.5 
kg/m² (19.1-
54) 
0.027 
OHG 21.9%  21.6%  0.97 
INSULIN 21.9%  26.8%  0.47 
BOTH 54.6%  46.3%  0.30 
F/H 41.2% 27.8%  0.07 
GBS= gallbladder stone, DM=diabetes mellitus, SD= standard 
deviation, BMI= body mass index, OHG=oral hypoglycemic drugs, 
F/H= family history 
 
The higher prevalence of GBS among females compared 
to males was more marked in diabetic patients younger 
than 50 years (42.5% vs.7.7%, p=0.02) than in those 
who were 50 years or older (51.8% in females vs. 37.1% 
in males, p=0.17). In the control group females were also 
more affected than males (18.3% vs. 15.8%). Diabetic 
patients with GBS were overall significantly older than 
those without GBS (mean 55.5 years vs. 50.5 years, 
p=0.007), (Table 2). Similarly, males with GBS were 
significantly older than their female counterparts (Table 
3). The prevalence of GBS among diabetics progressively 
increased with age (Figure 1).The age beyond which 
prevalence of GBS increased significantly was 41 years in 
females (p=0.01) and 53 years in males (p=0.003).There 
was no significant difference between diabetic patients 
with GBS and diabetic patients without GBS regarding 
duration of DM or type of treatment (oral, insulin or both) 
(Table 2).  
 
The mean BMI for diabetics with GBS was significantly 
higher, 34.78+/-6.29, than the mean BMI for diabetics 
without GBS, 32.2+/-7.5, (p=0.027). Risk of GBS 
increased significantly when BMI was over 24 kg/m2 
(p=0.019) (Figure 2). Moreover, the mean BMI of diabetic 
females with GBS was significantly higher than the mean 
BMI of diabetic males with GBS (p<0.001). A family 
history of GBS was found in 40.6% of patients with GBS 
and 27.8% of those without, but it was only in females 
that the difference (48% vs. 24.5%) was significant (p= 
0.011). The frequency of GBS progressively increased with 
number of pregnancies (Figure 3). About 50.5% of 
multiparus females had GBS as compared to 10% of 
nulliparus (p= 0.01). Mean parity of females with GBS 
(10.1+/-3.48; range: 0-17) was significantly higher (p= 
0.010) than mean parity of females without GBS (7.7+/-
4.7; range: 0-17).  About 44% of females with GBS were 
using oral contraceptives as compared to 42% of females 
without GBS (p= 0.84, both groups had almost the same 
mean age, mean duration of DM and mean BMI).  
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GBS was multiple in 75% of diabetics and 72% of 
controls, and no significant difference was found between 
males and females either (p= 0.29). About 73.4% of GBS 
patients were symptomatic and females were significantly 
more symptomatic than males (80% vs. 50%, p= 0.025). 
 
Discussion 
The prevalence of GBS among Libyan female diabetic 
patients was significantly higher than in non diabetic 
female outpatients, but a similar difference was not 
observed among males. Though no explanation can be 
offered, it is noteworthy that a similar observation was 
reported from New Zealand [7]. The rate of GBS in type-2 
Libyan diabetics in this study (40%) was higher than that 
reported from Italy (24.8%) [6] and nearly similar to what 
was reported from New Zealand (42.1%) in type-2 
diabetics [7], even though our patients were younger than 
the patients in the other two studies (Table 4). This high 
prevalence rate was maintained even when the sex 
distribution of the study populations was considered. This 
might reflect a higher risk of GBS among Libyans in 
general as a result of other contributing risk factors for 
GBS, such as genetic predisposition, obesity, multiparity 
and dietary habits. 
 
Diabetic women were 1.8 times more affected than 
diabetic men (47% vs. 26%, p=0.01), which agrees with 
observations of significantly higher prevalence of 
gallstones among diabetic and non diabetic women 
compared to men from all over the world [1,2,6,9]. The 
higher rate in women is probably due to the effects of sex 
hormones and pregnancy. Estrogen induces an increase in 
cholesterol secretion while progesterone induces reduction 
in bile acid secretion [10]. These changes eventually lead 
to supersaturation of bile with cholesterol, which facilitates 
gallstone formation. However, the higher prevalence we 
observed among females became statistically insignificant 
after the age of 50 when females were only 1.4 times 
more affected than males ( 51.8% vs. 37.1%,p-
value:0.17) as compared to 5.5 time in patients younger 
than 50 years old (42.5% vs.7.7%, p=0.02) . 
 
Age also is a well recognized risk factor for the 
gallstones in both diabetics and non diabetics [1,6,7,8]. 
The prevalence of GBS in diabetics older than 40 years 
was about three times higher than that in younger 
subjects (42% vs. 13%). Generally, patients with GBS 
were significantly older than those without GBS (55.5 
years vs. 50.5 years, p=0.007), and males with GBS were 
significantly older than females with GBS (62.9 vs. 53.5, 
p= 0.001). The cutoff age beyond which the GBS became 
significantly higher was 41 years in females (p= 0.01) and 
53 years in males (p=0.003). About three fourths of GBS 
patients were symptomatic and females were significantly 
more symptomatic than males (80% vs. 50%); whether 
females are really more symptomatic or whether they are 
just more expressive is not clear.  
 
Obesity and overweight are well-known risk factors for 
the development of gallstones, seemingly due to increased 
cholesterol synthesis and secretion [1,6,7,8,11]. The risk 
is particularly high in women [12]. Obesity was more 
prevalent in GBS diabetics than in non GBS diabetics 
(77.8% vs. 55.2%). Diabetics with GBS had a significantly 
higher BMI than those without GBS (34.78 kg/m² vs. 32.2 
kg/m², p=0.027). The cutoff BMI associated with 
significantly increased risk of GBS was 24 kg/m² 
(p=0.019), which is very near the top of the BMI normal 
range. Moreover, diabetic women with GBS were 
significantly more obese than diabetic men with GBS (36.3 
kg/m² vs. 29.46 kg/m ², p<0.001).  
 
A family history of GBS has been reported to be an 
important risk factor for GBS [1,6,7,13]. In our study, a 
family history of GBS was found in 41.2% of patients with 
GBS and in 27.8% of those without GBS. The difference 
bordered on statistical significance (p=0.07). We 
depended on the patients’ recall of family members with 
GBS, and if instead family members were screened with 
ultrasound the difference might have been more 
pronounced. Furthermore, a family history of GBS was 
significantly more prevalent among female patients with 
GBS (p=0.011).  
 
Pregnancy is a major risk factor for the development of 
gallstones [1,7] due to qualitative changes in bile and 
slowing of gallbladder emptying, which promotes bile 
stasis. The mean number of pregnancies of diabetic 
women with GBS was significantly higher than that of 
diabetic women without GBS (10.1 vs. 7.7, p=0.01). In 
comparison to nulliparus women, diabetic women who had 
been pregnant at least once before had a significantly 
higher prevalence of GBS (10% vs. 50.5%, p=0.01). This 
higher prevalence can not be attributed to age differences 
alone, as the mean ages of the two groups were not 
significantly different (46+/-8.9 vs. 40+/-18.7, p=0.13). 
 
Table 3 Comparison between male and  
female diabetics with GBS  
  All GBS 
patients  
Males with 
GBS  
Females 
with GBS  
P-
value  
Mean age 
(±SD)  
55.5±9.7 
years  
62.9± 8.5 
years  
53.5±9 
years  
0.001  
DM 
duration 
(±SD)  
12.5±7.7 
years  
13.7± 7.3 
years  
12.1± 7.9 
years  
0.49  
Mean 
weight 
(±SD)  
84.7±14.9 
kg  
82.5±12.1 
kg  
85.3±15.6 
kg  
0.5  
Mean BMI 
(±SD)  
34.78±6.29 
kg/m²  
29.46±4.3 
kg/m²  
36.3±5.9 
kg/m²  
<0.0
01  
Symptoms   73.4%  50%  80%  0.025  
Multiple 
GBS  
75%  64%  78%  0.29  
Family 
history  
40.6%  15.3%  48%  0.03  
GBS= gallbladder stone, DM=diabetes mellitus, BMI= body 
mass index, SD= standard deviation 
 
Oral contraceptive pills (OCP) are also believed to be 
associated with a slight increase in the risk of gallstone 
formation. However, in this study OCP did not seem to 
increase the risk of GBS in diabetic women, as there was 
no significant difference in the frequency of using OCP 
between diabetic women with and without GBS (44% vs. 
42%, p=0.84), and this is similar to results reported from 
Italy [6]. It has been shown that the frequency of GBS 
increased only slightly and transiently after starting oral 
contraceptives, and then the effect disappeared after 10 
years [14]. Another study stated that the use OCP only 
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marginally affects the incidence of GBS if at all [15]. On 
the other hand, the risk of GBS is highest when the 
estrogen dose is >50 µg [16], while the commonly used 
OCP in Libya over the past 10 years contain only 35 µg of 
estrogen, which might not be high enough to induce 
formation of a lithogenic bile.  
 
Table 4 comparison between GBS frequency among type-2 
diabetics in Libya, Italy and New Zealand  
  Libya  Italy  [6]   New 
Zealand [7]  
Number of 
patients  
161  1337  309  
Mean age  52.5±11.7 
years  
NR  57.9  years  
Mean age for 
females  
50.8±10.3 
years  
65±11 
years  
NR  
Mean age for 
males  
56±13.5 
years  
63± 11 
years  
NR  
GBS in all  39.8%  25%  42.1%  
GBS in Females  46.7%  29%  48.6%  
GBS in Males  25.9%  22%  33.3%  
GBS= gallbladder stone, NR= not reported  
 
Although the duration of DM in GBS patients (12.5+/-
7.7 years) was slightly longer than the duration in 
diabetics without GBS (10.6+/-6.8 years), this did not 
appear to affect the frequency of GBS, as the difference 
was not statistically significant. The type of treatment 
does not seem to influence the frequency of GBS as there 
was no significant difference between GBS and non GBS 
diabetics regarding the type of treatment (oral, insulin or 
both).  
 
Multiple GBS were detected in 75% of the cases, and 
there was no significant difference between diabetics and 
non diabetics or males and females regarding multiplicity 
of stones. 
 
Conclusions 
Libyan diabetic patients had a significantly higher 
prevalence of GBS than non diabetics (~2.3 times). 
Female diabetic patients were significantly more affected 
than males and the prevalence significantly increased with 
age particularly in males. Older age (>41 years in females 
and >53 years in males), high BMI (>24 kg/m²), female 
gender, and parity were the most significant risk factors 
for GBS in Libyan diabetic patients. By contrast, duration 
of DM, the type of hypoglycemic agent, and the use of 
OCP did not seem to influence the frequency of GBS 
among type 2 diabetics. Multiple GBS were the most 
common kind of GBS in diabetics, and the frequency of 
multiple and single GBS was similar among diabetics and 
non diabetics. 
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